Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. CbdMD, Inc.
  6. News
  7. Summary
    YCBD   US12482W1018

CBDMD, INC.

(YCBD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

cbdMD : Cantor Fitzgerald Adjusts Price Target for cbdMD to $3.25 from $4.10, Maintains Neutral Rating

06/18/2021 | 09:01am EDT


© MT Newswires 2021
All news about CBDMD, INC.
12:41aCBDMD : 12 Wellness Gifts for This Holiday Season...
PU
10/19CBDMD, INC. : Other Events (form 8-K)
AQ
10/13CBDMD : Everything You Need to Know About CBD Infused Drinks (+ 3 ...
PU
10/12FULL SPECTRUM CBD PRODUCTS : The Full Story...
PU
10/11CBDMD : Announces Official Multi-Year Partnership of the Wodapalooza Fitness Festival
BU
10/09CBDMD : What are the Benefits of Apple Cider Vinegar Gummies?...
PU
10/07CBDMD : Working With University of Mississippi to Identify Novel Cannabinoids for Therapeu..
MT
10/07CBDMD : Announces Research Partnership with the University of Mississippi, to Identify Nov..
BU
10/07CbdMD Announces Research Partnership with the University of Mississippi to Identify Nov..
CI
10/07CBD AND MENTAL HEALTH : Can It Help?...
PU
More news
Analyst Recommendations on CBDMD, INC.
More recommendations
Financials (USD)
Sales 2021 45,9 M - -
Net income 2021 -23,4 M - -
Net Debt 2021 33,0 M - -
P/E ratio 2021 -5,41x
Yield 2021 -
Capitalization 116 M 116 M -
EV / Sales 2021 3,23x
EV / Sales 2022 2,67x
Nbr of Employees 165
Free-Float 63,5%
Chart CBDMD, INC.
Duration : Period :
cbdMD, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CBDMD, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 2,00 $
Average target price 3,70 $
Spread / Average Target 85,0%
EPS Revisions
Managers and Directors
Martin A. Sumichrast Chairman & Co-Chief Executive Officer
Raymond Scott Coffman President, Co-Chief Executive Officer & Director
T. Ronan Kennedy Chief Operating & Financial Officer
Sibyl Swift Vice President-Scientific & Regulatory Affairs
Bakari Sellers Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CBDMD, INC.-32.20%116
JOHNSON & JOHNSON4.12%431 385
ROCHE HOLDING AG15.84%337 562
NOVO NORDISK A/S57.04%239 813
PFIZER, INC.12.25%235 986
ELI LILLY AND COMPANY43.51%219 674